Literature DB >> 28644540

Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.

Rob Noorlag1, Robert J J van Es2, Remco de Bree2, Stefan M Willems3.   

Abstract

BACKGROUND: Intraoperative analysis of lymph nodes during a sentinel lymph node biopsy (SLNB) procedure could result in one-step surgery for early oral squamous cell carcinoma (OSCC) with an occult nodal metastasis. One-step nucleic acid amplification rapidly detects cytokeratin 19 (CK19) RNA with high accuracy. Sensitivity and specificity of CK19 expression in OSCC was evaluated.
METHODS: Immunohistochemical CK19 expression was done in 207 patients with OSCC with 65 cases of paired nodal metastases.
RESULTS: CK19 was expressed in 65% of all OSCC and even less in early OSCC (56%), with poor correlation between primary tumor and (occult) nodal metastasis. Furthermore, ectopic glandular tissue in close proximity of lymph nodes showed strong CK19 expression.
CONCLUSION: CK19 lacks both sensitivity and specificity as a biomarker for nodal metastasis in OSCC, which questions the suitability for CK19-based one-step nucleic acid amplification in SLNB procedures. Therefore, future studies should focus on other biomarkers, because the concept of fast intraoperative diagnostics during SLNB remains attractive.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytokeratin 19; one-step nucleic acid amplification; oral cancer; sentinel lymph node biopsy (SLNB)

Mesh:

Substances:

Year:  2017        PMID: 28644540     DOI: 10.1002/hed.24847

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological Procedure.

Authors:  Josef Vodicka; Martin Pesta; Vlastimil Kulda; Katerina Houfkova; Bohuslava Vankova; Jakub Sebek; Martin Skala; Jakub Fichtl; Kristyna Prochazkova; Ondrej Topolcan
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.